Replies to post #124948 on DD Support Board and Research Team

[janice shell]

I know this is a theoretical question, but I'm trying to wrap my head around how a man like this gets involved in all this.

That's one of the key questions about BVTK, and it's been a question with other high-flying penny stocks. SKTO was endorsed by the Lieutenant Governor of California. Alexander Haig participated in TV pumps of total scams. There are more examples.

But those people were never CEO of a penny company. Some have been board members, but not part of management. So perhaps they can be excused, at least in part, because they probably weren't being told all they needed to know. Of course, they evidently didn't ask many questions, either.

Is it *really* just about money and he is in on the scam? Or perhaps he means well but is so deep in with the convertible debt now is just trying to stay for afloat?

Either is possible. There are many CEOs who start off planning to develop a real business, but quickly realize they're not going to get conventional financing. They may initially not understand the terms of toxic funding, or think they'll somehow manage to pay off the loans before the lenders are able to convert, but that's not how it works. Eventually, many simply realize it's easier to sell stock than to run a business.

[236T568]

You mean BVTK?

the company that recently issued a press release CEO's Letter to Fellow Shareholders and signed it by using his first name "Tom" and no last name?

that BVTK?


http://www.nasdaq.com/press-release/bravatek-ceos-letter-to-fellow-shareholders-20170601-00466

So I'm relatively new to the OTC world, but I find it both strange and fascinating. This board in particular has been quite enlightening.

My question is regarding BVTK, I apologize in advance if this has been covered but I haven't seen anything about him. The CEO was previously in govt and has what appears to be a strong resume and reputation (not that I exactly trust govt but that's another discussion I believe). I see that many of these tickers and ceos are quite easily exposed due to past dealings. I know this is a theoretical question, but I'm trying to wrap my head around how a man like this gets involved in all this. Is it *really* just about money and he is in on the scam? Or perhaps he means well but is so deep in with the convertible debt now is just trying to stay for afloat? The hype and cult following of this stock is...entertaining to say the least.

Thanks for any input.

[236T568]

here you go:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=121969921

freebies
Saturday, 04/16/16 12:55:49 PM
Re: None
Post #
106861
of 124997 Go

WORST CROOKED LIAR CEO-AWARD GOES TO TOM CELLUCCI BVTK

Jmo

So I'm relatively new to the OTC world, but I find it both strange and fascinating. This board in particular has been quite enlightening.

My question is regarding BVTK, I apologize in advance if this has been covered but I haven't seen anything about him. The CEO was previously in govt and has what appears to be a strong resume and reputation (not that I exactly trust govt but that's another discussion I believe). I see that many of these tickers and ceos are quite easily exposed due to past dealings. I know this is a theoretical question, but I'm trying to wrap my head around how a man like this gets involved in all this. Is it *really* just about money and he is in on the scam? Or perhaps he means well but is so deep in with the convertible debt now is just trying to stay for afloat? The hype and cult following of this stock is...entertaining to say the least.

Thanks for any input.

[236T568]

and more: BVTK - ISSUES DEEP DISCOUNT DEATH SPIRAL TOXIC CONVERTIBLE NOTES DURING LAST FEW MONTHS:

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12224825

On May 1, 2017, the Company issued to a third-party investor, three convertible notes, two of which were for $50,000 each and one for $17,500, and three back end convertible notes, two of which were for $50,000 each and one for $25,000. All of the notes have a stated interest of 8% and each note is convertible at any time following the funding of such note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six month anniversary of the note the conversion price shall have ceiling of $0.0005. The three convertible notes were funded on May 1, 2017, when the Company received proceeds of $111,625, excluding transaction costs, fees and expenses.

On May 1, 2017, the Company issued to a third-party investor, three convertible notes, two of which were for $50,000 each and one for $17,500, and three back end convertible notes, two of which were for $50,000 each and one for $25,000. All of the notes have a stated interest of 8% and each note is convertible at any time following the funding of such note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. . Beginning on the six month anniversary of the note the conversion price shall have ceiling of $0.0005.The three convertible notes were funded on April 28, 2017 and May 3, 2017, when the Company received proceeds of $85,000 and $26,625, respectively, after disbursements for the lender’s transaction costs, fees and expenses.

On May 2, 2017, the Company issued a convertible note for legal services previously provided with a face value of $23,000 and stated interest of 10% to a third-party investor. The note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 70% of the average of the three lowest closing bid prices for 10 days prior to conversion.

On May 3, 2017, the Company issued a convertible promissory note, with a face value of $124,775 and stated interest of 10% to Carebourn. The note is convertible at any time after ninety days following the funding of the note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note was funded on May 4, 2017, when the Company received proceeds of $100,000, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires 240 daily payments of $520 per day via ACH.

On June 8, 2017, the Company issued to a third-party investor a convertible promissory note for $140,750 and a back end convertible note for $140,750. The notes have a stated interest of 8% and each note is convertible at any time following the funding of such note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six month anniversary of the note the conversion price shall have ceiling of $0.0005.The note was funded on June 15, 2017, when the Company received proceeds of $135,000, after disbursements for the lender’s transaction costs, fees and expenses.

On June 8, 2017, the Company issued to a third-party investor a convertible promissory note for $140,750 and a back end convertible note for $140,750. The notes have a stated interest of 8% and each note is convertible at any time following the funding of such note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six month anniversary of the note the conversion price shall have ceiling of $0.0005.The note was funded on June 15, 2017, when the Company received proceeds of $135,000, after disbursements for the lender’s transaction costs, fees and expenses.

On June 9, 2017, the Company issued a convertible promissory note, with a face value of $165,025 and stated interest of 10% to Carebourn. The note is convertible at any time after ninety days following the funding of the note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note was funded on May 12, 2017, when the Company received proceeds of $135,000, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires 240 daily payments of $680 per day via ACH.

On June 23, 2017, the Company issued a convertible promissory note, with a face value of $262,775 and stated interest of 10% to Carebourn. The note is convertible at any time after ninety days following the funding of the note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note was funded on June 23, 2017, when the Company received proceeds of $220,000, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires 180 daily payments of $1,460 per day via ACH.

So I'm relatively new to the OTC world, but I find it both strange and fascinating. This board in particular has been quite enlightening.

My question is regarding BVTK, I apologize in advance if this has been covered but I haven't seen anything about him. The CEO was previously in govt and has what appears to be a strong resume and reputation (not that I exactly trust govt but that's another discussion I believe). I see that many of these tickers and ceos are quite easily exposed due to past dealings. I know this is a theoretical question, but I'm trying to wrap my head around how a man like this gets involved in all this. Is it *really* just about money and he is in on the scam? Or perhaps he means well but is so deep in with the convertible debt now is just trying to stay for afloat? The hype and cult following of this stock is...entertaining to say the least.

Thanks for any input.